Review of neuropathic pain screening and assessment tools

Current Pain and Headache Reports

Volumn 17, Issue 9, 2013, Pages

  Jones, R Carter W ^a   Backonja, Miroslav Misha ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CRILifetree Clinical Research   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Assessment; DN 4; ID pain; LANSS; Neuropathic pain; NPQ; NPS; NPSI; painDETECT; Screening; SF MPQ 2; StEP

Indexed keywords

CLINICAL ASSESSMENT TOOL; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOULEUR NEUROPATHIQUE 4 QUESTIONS; HUMAN; ID PAIN; LEEDS ASSESSMENT OF NEUROPATHIC SYMPTOMS AND SIGNS; NEUROPATHIC PAIN; NEUROPATHIC PAIN QUESTIONNAIRE; NEUROPATHIC PAIN SCALE; NEUROPATHIC PAIN SYMPTOM INVENTORY; PAIN ASSESSMENT; PAINDETECT; PHYSICAL EXAMINATION; QUESTIONNAIRE; RATING SCALE; REVIEW; SCREENING; SELF REPORT; SENSITIVITY AND SPECIFICITY; SHORT FORM MCGILL PAIN QUESTIONNAIRE 2; STANDARDIZED EVALUATION OF PAIN; SYMPTOM; CHRONIC PAIN; METHODOLOGY; NEURALGIA; PAIN MEASUREMENT; PROCEDURES;

CHRONIC PAIN; HUMANS; NEURALGIA; PAIN MEASUREMENT;

EID: 84883067466     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-013-0363-6     Document Type: Review

References (41)

1. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630-5. (Pubitemid 351620320)
2. • Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147-57. This is the first published assessment tool with the purpose of discriminating NP from nonNP, though a few others were developed at approximately same time. (Pubitemid 32367946)
3. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6:149-58. (Pubitemid 40365018)
4. Li J, Feng Y, Han J, Fan B, Wu D, Zhang D, et al. Linguistic adaptation, validation and comparison of 3 routinely used neuropathic pain questionnaires. Pain Physician. 2012;15:179-86.
5. Unal-Cevik I, Sarioglu-Ay S, Evcik D. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4. J Pain. 2010;11:1129-35.
6. Gürsoy AE, KolukIsa M, YIldIz GB. Relationship between electrodiagnostic severity and neuropathic pain assessed by the LANSS pain scale in carpal tunnel syndrome. Neuropsychiatr DisTreat. 2013;9:65-71.
7. TürkyIlmaz AK, Kurt EE, ÇapkIn E, Karkucak M. Assessment of Neuropathic Pain in Patients with Fibromyalgia Syndrome: A Pilot Study. J Muscoskeletal Pain Informa Healthcare New York, USA. 2012;20:170-6.
8. Burgess PR, Perl ER. Myelinated afferent fibres responding specifically to noxious stimulation of the skin. J Physiol (Lond). 1967;190:541-62.
9. Krause SJ, Backonja M-M. Development of a neuropathic pain questionnaire. Clin J Pain. 2003;19:306-14. (Pubitemid 37075671)
10. •• Backonja M-M, Krause SJ. Neuropathic pain questionnaire - short form. Clin J Pain. 2003;19:315-6. Shortest three-questions tool that is still able to provide differentiation between NP and nonNP. (Pubitemid 37075672)
11. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29-36. (Pubitemid 40279084)
12. Jambart S, Ammache Z, Haddad F, Younes A, Hassoun A, Abdalla K, et al. Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region. J Int Med Res. 2011;39:366-77.
13. de Moraes Vieira EB, Garcia JBS, da Silva AAM, Mualem Araujo RLT, Jansen RCS. Prevalence, characteristics, and factors associated with chronic pain with and without neuropathic characteristics in Sao Luis. Brazil J Pain Symptom Manage. 2012;44:239-51.
14. Lekpa FK, Ndongo S, Ka O, Zeba D, Compaore C, Pouye A, et al. Socio-demographic and clinical profile of chronic pain with neuropathic characteristics in sub-Saharan African elderly. Eur J Pain 17: 939-43.
15. • Truini A, Padua L, Biasiotta A, Caliandro P, Pazzaglia C, Galeotti F, et al. Differential involvement of A-delta and A-beta fibres in neuropathic pain related to carpal tunnel syndrome. Pain. 2009;145:105-9. This is a particularly interesting study demonstrating correlation of symptom description in neuropathic pain with abnormalities in the function of specific types of peripheral afferent neuronal fibers.
16. Correa-Illanes G, Roa R, Piñeros JL, Calderón W. Use of 5 % lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves. Local Reg Anesth. 2012;5:47-53.
17. Sadler A, Wilson J, Colvin L. Acute and Chronic Neuropathic Pain in the. Use of Screening Tools. Clin J Pain.: Hospital Setting; 2012.
18. Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911-20. (Pubitemid 44663395)
19. Rados I, Sakic Zdravcevic K, Hrgovic Z. painDETECT questionnaire and lumbar epidural steroid injection for chronic radiculopathy. Eur Neurol. 2013;69:27-32.
20. Reyes-Gibby C, Morrow PK, Bennett MI, Jensen MP, Shete S. Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool. J Pain Symptom Manage. 2010;39:882-9.
21. • Scholz J, Mannion RJ, Hord DE, Griffin RS, Rawal B, Zheng H, et al. (2009) A Novel Tool for the Assessment of Pain: Validation in Low Back Pain. Rice A, editor. PLoS Med 6: e1000047. This paper describes the development of the StEP assessment tool, which has the highest reported sensitivity and specificity, even greater than MRI imaging, for the identification neuropathic low back pain. It also has the most involved physical exam components, and consequently likely requires the most time to perform of any of the tools.
22. •• Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997;48:332-8. This is the first published tool designed to assess the severity of NP symptoms. (Pubitemid 27087598)
23. Fishbain DA, Lewis JE, Cutler R, Cole B, Rosomoff HL, Rosomoff RS. Can the neuropathic pain scale discriminate between non-neuropathic and neuropathic pain? Pain Med. 2008;9:149-60. (Pubitemid 351285409)
24. Hartrick CT, Kovan JP, Naismith P. Outcome prediction following sympathetic block for complex regional pain syndrome. Pain Pract. 2004;4:222-8.
25. Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5 % effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002;18:297-301. (Pubitemid 35001155)
26. Tai Q, Kirshblum S, Chen B, Millis S, Johnston M, DeLisa JA. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med. 2002;25:100-5. (Pubitemid 36834703)
27. Jensen MP, Gammaitoni AR, Olaleye DO, Oleka N, Nalamachu SR, Galer BS. The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome. J Pain. 2006;7:823-32. (Pubitemid 44740532)
28. Rog DJ, Nurmikko TJ, Friede T, Young CA. Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis. Clin J Pain. 2007;23:473-81. (Pubitemid 46956183)
29. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004;108:248-57. (Pubitemid 38353047)
30. Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy and safety of 5 % lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Investig. 2009;29:231-41.
31. Moulin DE, Richarz U, Wallace M, Jacobs A, Thipphawong J. Efficacy of the sustained-release hydromorphone in neuropathic pain management: pooled analysis of three open-label studies. J Pain Palliat Care Pharmacother. 2010;24:200-12.
32. Attal N, Fermanian C, Fermanian J, Lanteri-Minet M, Alchaar H, Bouhassira D. Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain. 2008;138:343-53.
33. Pazzaglia C, Vollono C, Ferraro D, Virdis D, Lupi V, Le Pera D, et al. Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: a laser-evoked potential study. Pain. 2010;149:379-85.
34. Sommer C, Richter H, Rogausch JP, Frettloh J, Lungenhausen M, Maier C. A modified score to identify and discriminate neuropathic pain: a study on the German version of the Neuropathic Pain Symptom Inventory (NPSI). BMC Neurol. 2011;11:104.
35. Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009;144:35-42.
36. Saldana MT, Perez C, Navarro A, Masramón X, Rejas J. Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice. Clin Drug Investig. 2012;32:401-12.
37. Gilron I, Tu D, Holden RR. Sensory and affective pain descriptors respond differentially to pharmacological interventions in neuropathic conditions. Clin J Pain. 2013;29:124-31.
38. Atalay H, Solak Y, Biyik Z, Gaipov A, Guney F, Turk S. Cross-Over, Open-Label Trial of the Effects of Gabapentin versus Pregabalin on Painful Peripheral Neuropathy and Health-Related Quality of Life in Haemodialysis Patients. Clin Drug Investig. 2013;33:401-8.
39. Adelmanesh F, Jalali A, Attarian H, Farahani B, Ketabchi SM, Arvantaj A, et al. Reliability, validity, and sensitivity measures of expanded and revised version of the short-form McGill Pain Questionnaire (SF-MPQ-2) in Iranian patients with neuropathic and non-neuropathic pain. Pain Med. 2012;13:1631-6.
40. Bennett MI, Attal N, Backonja MM, Baron R, Bouhassira D, Freynhagen R, et al. Using screening tools to identify neuropathic pain. Pain. 2007;127:199-203. (Pubitemid 46084881)
41. Gilron I, Attal N, Bouhassira D, Dworkin RH (2010) Assessment of Neuropathic Pain. Turk DC, Melzack R, editors. Handbook of Pain Assessment. 3rd ed. The Guilford Press